Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

PMID:
26549003
2.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
3.

A French national survey on the use of antibiotic prophylaxis in cirrhotic patients.

Thevenot T, Degand T, Grelat N, Elkrief L, Christol C, Moreau R, Henrion J, Cadranel JF, Sheppard F, Bureau C, di Martino V, Pauwels A; National Association of General Hospital Hepatogastroenterologists.

Liver Int. 2013 Mar;33(3):389-97. doi: 10.1111/liv.12093. Epub 2013 Jan 10.

PMID:
23302021
4.

Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study.

Nahon S, Hagège H, Latrive JP, Rosa I, Nalet B, Bour B, Faroux R, Gower P, Arpurt JP, Denis J, Henrion J, Rémy AJ, Pariente A; Groupe des Hémorragies Digestives Hautes de l’ANGH.

Endoscopy. 2012 Nov;44(11):998-1008. doi: 10.1055/s-0032-1310006. Epub 2012 Oct 29.

PMID:
23108771
5.

Epidemiology and adherence to guidelines on the management of bleeding peptic ulcer: a prospective multicenter observational study in 1140 patients.

Zeitoun JD, Rosa-Hézode I, Chryssostalis A, Nalet B, Bour B, Arpurt JP, Denis J, Nahon S, Pariente A, Hagège H; Groupe des Hémorragies Digestives Hautes de l’ANGH.

Clin Res Hepatol Gastroenterol. 2012 Jun;36(3):227-34. doi: 10.1016/j.clinre.2011.11.008. Epub 2012 Feb 3.

PMID:
22306054
6.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group.

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23.

PMID:
22271569
7.

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group.

Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.

PMID:
21708105
8.

Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise.

Heresbach D, Djabbari M, Riou F, Marcus C, Le Sidaner A, Pierredon-Foulogne MA, Ponchon T, Boudiaf M, Seyrig JA, Laumonier H, Luet D, Giraud-Cohen M, Pelletier AL, Charachon A, Ramaholimihaso F, Bouillet P, Veyrac M, Ficarelli S, Vahedi K, Keruhel J, Lamouliatte H, Ridereau-Zins C, Bouhnik Y, Tissier M, Diris B, Zagdanski AM, Josselin JM, Hamonic S, Gandon Y.

Gut. 2011 May;60(5):658-65. doi: 10.1136/gut.2010.225623. Epub 2011 Jan 25.

PMID:
21266723
9.

Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations.

Pariente A, Lahmek P, Duprat C, Denis J, Faroux R, Renou C, Nalet B, Morin T, Cadranel JF; Investigator Group belonging to Association Nationale des Gastroentérologues des Hôpitaux Généraux (ANGH).

Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1297-302.

PMID:
20964260
10.

A national survey of endoscopic mucosal resection for superficial gastrointestinal neoplasia.

Heresbach D, Kornhauser R, Seyrig JA, Coumaros D, Claviere C, Bury A, Cottereau J, Canard JM, Chaussade S, Baudet A, Casteur A, Duval O, Ponchon T; OMEGA group.

Endoscopy. 2010 Oct;42(10):806-13. doi: 10.1055/s-0030-1255715. Epub 2010 Sep 6.

PMID:
20821362
11.

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F; CESAME Study Group.

Lancet. 2009 Nov 7;374(9701):1617-25. doi: 10.1016/S0140-6736(09)61302-7.

PMID:
19837455
12.

Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.

Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Politis J, Richecoeur M, Robaszkiewicz M, Seyrig JA; ABERMAD (Association Bretonne d'Etude et de Recherche sur les Maladies de l'Appareil Digestif).

Gut. 2005 Feb;54(2):215-22.

13.

Crohn's disease in the over-60 age group: a population based study.

Heresbach D, Alexandre JL, Bretagne JF, Cruchant E, Dabadie A, Dartois-Hoguin M, Girardot PM, Jouanolle H, Kerneis J, Le Verger JC, Louvain V, Pennognon L, Richecoeur M, Politis J, Robaszkiewicz M, Seyrig JA, Tron I; ABERMAD.

Eur J Gastroenterol Hepatol. 2004 Jul;16(7):657-64. Review.

PMID:
15201578
14.

[Multicenter prospective study of prognostic factors of gastroduodenal ulcer hemorrhages. Reevaluation of clinical and endoscopic factors in the era of endoscopic hemostasis].

Bourienne A, Pagenault M, Heresbach D, Jacquelinet C, Faroux R, Lejean-Colin I, Person B, Masliah C, Nouel O, Seyrig JA, Gosselin M, Bretagne JF.

Gastroenterol Clin Biol. 2000 Feb;24(2):193-200. French.

PMID:
12687961
15.

[Prolonged prothrombin time: don't overlook amyloidosis].

Abdulahad J, Lamy T, Costa B, Seyrig JA.

Gastroenterol Clin Biol. 2002 Jun-Jul;26(6-7):639-40. French. No abstract available.

16.

[Patients with alcoholic liver disease hospitalized in gastroenterology. A national multicenter study].

Naveau S, Giraud V, Ganne N, Perney P, Hastier P, Robin E, Pessione F, Chossegros P, Lahmek P, Fontaine H, Ribard D, Dao T, Filoche B, El Jammal G, Seyrig JA, Dramard JM, Chousterman M, Pillegand B.

Gastroenterol Clin Biol. 2001 Feb;25(2):131-6. French.

17.

[Outcome of unclassified colitis in the ABERMAD register (inflammatory bowel disease). Effect of follow-up on incidence. Breton Association for Study and Research on Digestive System Diseases].

Dabadie A, Tourtelier Y, Alexandre JL, Robaskiewicz M, Cruchant E, Seyrig JA, Heresbach D, Tron I, Bretagne JF.

Arch Pediatr. 2000 Sep;7(9):1011. French. No abstract available.

PMID:
11028214
18.

[Incidence of inflammatory bowel disease in children in Brittany (1994-1997). Breton association of study and research on digestive system diseases (Abermad)].

Tourtelier Y, Dabadie A, Tron I, Alexandre JL, Robaskiewicz M, Cruchant E, Seyrig JA, Heresbach D, Bretagne JF.

Arch Pediatr. 2000 Apr;7(4):377-84. French.

PMID:
10793924
19.

A kappa opiate agonist, U50,488H, enhances energy expenditure in rats.

Mandenoff A, Seyrig JA, Betoulle D, Brigant L, Melchior JC, Apfelbaum M.

Pharmacol Biochem Behav. 1991 May;39(1):215-7.

PMID:
1656474
20.

[Asthma related to hydatid cyst].

Costa B, Seyrig JA, Cugnenc P, Barbier JP.

Presse Med. 1990 Jun 9;19(23):1105-6. French. No abstract available.

PMID:
2141421
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk